DGAP-News: Press Release: 4SC announces improved financial results for the third quarter and first nine months of 2013

DGAP-News: 4SC AG / Key word(s): Quarter Results/Miscellaneous Press Release: 4SC announces improved financial results for the third quarter and first nine months of 2013

07.11.2013 / 07:31

---------------------------------------------------------------------

Press Release

4SC announces improved financial results for the third quarter and first nine months of 2013

Planegg-Martinsried, Germany, 7 November 2013 - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, today announced the financial results for the 4SC Group in accordance with International Financial Reporting Standards (IFRS) for the third quarter and first nine months of 2013.

Operating highlights in Q3 (1 July - 30 September 2013):

- Resminostat: Expression of ZFP64 biomarker and other patient characteristics strongly correlate with patient survival in liver cancer (HCC) and Hodgkin's lymphoma; study results presented at ILCA (Washington) and ECCO (Amsterdam) research conferences

- Resminostat: Partner Yakult Honsha starts clinical development in non-small-cell lung cancer (NSCLC) in Japan, making this the fourth tumour indication

- 4SC-202: Patent protection in China, Hong Kong and the USA expanded significantly

See more here:
DGAP-News: Press Release: 4SC announces improved financial results for the third quarter and first nine months of 2013

Related Posts

Comments are closed.